BDBM404307 2-{5-[(3R,6R)-1-{[2-(2,2- Difluorocyclopropyl)phenyl] carbonyl}-6-methylpiperidin-3- yl]isoxazol-3-yl}propan-2-ol::US10017504, 38

SMILES C[C@@H]1CC[C@H](CN1C(=O)c1ccccc1C1CC1(F)F)c1cc(no1)C(C)(C)O

InChI Key InChIKey=BFWJJTJZXMESQY-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 404307   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM404307(2-{5-[(3R,6R)-1-{[2-(2,2- Difluorocyclopropyl)phen...)
Affinity DataIC50: 52.4nMAssay Description:n a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM404307(2-{5-[(3R,6R)-1-{[2-(2,2- Difluorocyclopropyl)phen...)
Affinity DataIC50: 7.78E+3nMAssay Description:n a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2020
Entry Details
US Patent